id: daidzein_treatment_to_nox4_inhibition
name: Daidzein Treatment (Soy Isoflavone) â†’ NOX-4 Enzyme Inhibition
from_node:
  node_id: daidzein_treatment
  node_name: Daidzein Treatment (Soy Isoflavone)
to_node:
  node_id: nox4_inhibition
  node_name: NOX-4 Enzyme Inhibition
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Daidzein administration reduces NOX-4 overexpression in sciatic nerve tissue'
- 'Step 2: Reduced NOX-4 activity decreases reactive oxygen species generation'
- 'Step 3: Enhancement of antioxidant enzyme levels further protects against oxidative
  damage'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: A. Laddha and Yogesh A. Kulkarni 2024. "Daidzein ameliorates peripheral
    neuropathy in Sprague Dawley rats." *Frontiers in Pharmacology*. https://doi.org/10.3389/fphar.2024.1385419
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.266788'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: daidzein_dose
  direction: strengthens
  strength: moderate
  description: Study tested varying doses (25, 50, 100 mg/kg), suggesting dose-dependent
    effects on NOX-4 inhibition
- name: treatment_duration
  direction: strengthens
  strength: moderate
  description: Four weeks of treatment duration allowed sufficient time for molecular
    changes in nerve tissue
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/daidzein_treatment_to_nox4_inhibition.yaml
_category: biological
